{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:42:48Z","timestamp":1793216568004,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T00:00:00Z","timestamp":1571961600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41433-019-0622-9","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T18:22:55Z","timestamp":1572027775000},"page":"1699-1706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Uveal melanoma-associated survival in Scotland"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-443X","authenticated-orcid":false,"given":"Aaron","family":"Jamison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manvi M.","family":"Sobti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Chadha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan G.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,25]]},"reference":[{"key":"622_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ohc.2004.07.002","volume":"18","author":"AD Singh","year":"2005","unstructured":"Singh AD, Bergman L, Seregard S. Uveal melanoma: epidemiologic aspects. Ophthalmol Clin North Am. 2005;18:75\u201384.","journal-title":"Ophthalmol Clin North Am"},{"key":"622_CR2","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/eye.2015.51","volume":"29","author":"CL Shields","year":"2015","unstructured":"Shields CL, Kaliki S, Cohen MN, Shields PW, Furuta M, Shields JA. Prognosis of uveal melanoma based on race in 8100 patients: the 2015 Doyne Lecture. Eye. 2015;29:1027\u201335.","journal-title":"Eye"},{"key":"622_CR3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/cncr.20866","volume":"103","author":"CC McLaughlin","year":"2005","unstructured":"McLaughlin CC, Wu XC, Jemal A, Martin HJ, Roche LM, Chen VW. Incidence of noncutaneous melanomas in the U.S. Cancer. 2005;103:1000\u20137.","journal-title":"Cancer."},{"key":"622_CR4","first-page":"280","volume":"11","author":"S Frenkel","year":"2009","unstructured":"Frenkel S, Hendler K, Pe\u2019er J. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis. Isr Med Assoc J. 2009;11:280\u20135.","journal-title":"Isr Med Assoc J"},{"key":"622_CR5","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","volume":"118","author":"AD Singh","year":"2011","unstructured":"Singh AD, Turell ME, Topham AK. Uveal melanoma: trends in incidence, treatment, and survival. Ophthalmology. 2011;118:1881\u20135.","journal-title":"Ophthalmology"},{"key":"622_CR6","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1001\/archopht.126.10.1413","volume":"126","author":"G Virgili","year":"2008","unstructured":"Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E. et al. EUROCARE working group, survival in patients with uveal melanoma in Europe. Arch Ophthalmol. 2008;126:1413\u20138.","journal-title":"Arch Ophthalmol"},{"key":"622_CR7","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1167\/iovs.03-0538","volume":"44","author":"E Kujala","year":"2003","unstructured":"Kujala E, M\u00e4kitie T, Kivel\u00e4 T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"622_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/0301-4738.154367","volume":"63","author":"S Kaliki","year":"2015","unstructured":"Kaliki S, Shields CL, Shields JA. Uveal melanoma: estimating prognosis. Indian J Ophthalmol. 2015;63:93\u2013102.","journal-title":"Indian J Ophthalmol"},{"key":"622_CR9","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1001\/archopht.123.12.1639","volume":"123","author":"The Collaborative Ocular Melanoma Study Group.","year":"2005","unstructured":"The Collaborative Ocular Melanoma Study Group. Development of metastatic disease after enrolment in the COMS trials for treatment of choroidal melanoma. COMS report no. 26. Arch Ophthalmol. 2005;123:1639\u201343.","journal-title":"Arch Ophthalmol"},{"key":"622_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0046-8177(82)80116-0","volume":"13","author":"IW McLean","year":"1982","unstructured":"McLean IW, Foster WD, Zimmerman LE. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol. 1982;13:123\u201332.","journal-title":"Hum Pathol"},{"key":"622_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/j.1600-0420.1995.tb00039.x","volume":"73","author":"S Seregard","year":"1995","unstructured":"Seregard S, Kock E. Prognostic indicators following enucleation for posterior uveal melanoma. A multivariate analysis of long-term survival with minimized loss to follow-up. Acta Ophthalmol Scand. 1995;73:340\u20134.","journal-title":"Acta Ophthalmol Scand"},{"key":"622_CR12","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1001\/archopht.1983.01040020896012","volume":"101","author":"JM Seddon","year":"1983","unstructured":"Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983;101:1894\u20139.","journal-title":"Arch Ophthalmol"},{"key":"622_CR13","first-page":"1230","volume":"6","author":"P Jovanovic","year":"2013","unstructured":"Jovanovic P, Mihajlovic M, Djordjevic-Jocic J, Vlajkovic S, Cekic S, Stefanovic V. Ocular melanoma: an overview of the current status. Int J Clin Exp Pathol. 2013;6:1230\u201344.","journal-title":"Int J Clin Exp Pathol."},{"key":"622_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/sj.bjc.6605765","volume":"103","author":"B Damato","year":"2010","unstructured":"Damato B. Does ocular treatment of uveal melanoma influence survival? Br J Cancer. 2010;103:285\u201390.","journal-title":"Br J Cancer"},{"key":"622_CR15","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S0161-6420(03)00077-0","volume":"110","author":"AD Singh","year":"2003","unstructured":"Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973\u20131997. Ophthalmology. 2003;110:962\u20135.","journal-title":"Ophthalmology"},{"key":"622_CR16","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ajo.2004.07.006","volume":"138","author":"The Collaborative Ocular Melanoma Study Group.","year":"2004","unstructured":"The Collaborative Ocular Melanoma Study Group. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma IV: ten-year mortality findings and prognostic factors. COMS report no. 24. Am J Ophthalmol. 2004;138:936\u201351.","journal-title":"Am J Ophthalmol"},{"key":"622_CR17","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","volume":"127","author":"CL Shields","year":"2009","unstructured":"Shields CL, Furuta M, Thangappan A. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127:989\u201398.","journal-title":"Arch Ophthalmol"},{"key":"622_CR18","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/IAE.0b013e31824d09a8","volume":"32","author":"CL Shields","year":"2012","unstructured":"Shields CL, Kaliki S, Furuta M, Mashayekhi A, Shields JA. Clinical spectrum and prognosis of uveal melanoma based on age at presentation in 8,033 cases. Retina. 2012;32:1363\u201372.","journal-title":"Retina"},{"key":"622_CR19","unstructured":"Edge SB, Byrd DR, Compton CC (eds). AJCC Cancer Staging Manual, 7th edn. Springer: New York, NY; 2010."},{"key":"622_CR20","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.2012.45.2771","volume":"31","author":"E Kujala","year":"2013","unstructured":"Kujala E, Damato B, Coupland SE, Desjardins L, Bechrakis NE, Grange JD. et al. Staging of ciliary body and choroidal melanomas based on anatomic extent. J Clin Oncol. 2013;31:2825\u201331.","journal-title":"J Clin Oncol"},{"key":"622_CR21","unstructured":"National Records of Scotland, Edinburgh, UK. \n                    http:\/\/www.nrscotland.gov.uk\/\n                    \n                  . Accessed 15 Apr 18."},{"key":"622_CR22","unstructured":"Information Services Division Scotland, National Services Scotland, NHS Scotland, UK. \n                    http:\/\/www.isdscotland.org\/\n                    \n                  . Accessed 15 Apr 18."},{"key":"622_CR23","unstructured":"Scottish Government. Part I \u2013 context and developments since 2006. In: Community eyecare services review. Scotland, UK: Scottish Government. \n                    https:\/\/www.gov.scot\/Publications\/2017\/04\/7983\n                    \n                  . Accessed 30 Aug 18."},{"key":"622_CR24","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1111\/j.1365-2559.2005.02243.x","volume":"47","author":"J Roulson","year":"2005","unstructured":"Roulson J, Benbow EW, Hasleton PS. Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology. 2005;47:551\u20139.","journal-title":"Histopathology"},{"key":"622_CR25","first-page":"192","volume":"15","author":"G Maudsley","year":"1993","unstructured":"Maudsley G, Williams EM. Death certification by house officers and general practitioners\u2014practice and performance. J Public Health Med. 1993;15:192\u2013201.","journal-title":"J Public Health Med"},{"key":"622_CR26","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/eye.2012.126","volume":"26","author":"B Damato","year":"2012","unstructured":"Damato B. Progress in the management of patients with uveal melanoma. The 2012 Ashton Lecture. Eye. 2012;26:1157\u201372.","journal-title":"Eye"},{"key":"622_CR27","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1001\/archopht.125.7.966","volume":"125","author":"B Damato","year":"2007","unstructured":"Damato B. Legacy of the collaborative ocular melanoma study. Arch Ophthalmol. 2007;125:966\u20138.","journal-title":"Arch Ophthalmol"},{"key":"622_CR28","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1159\/000492391","volume":"5","author":"C Baily","year":"2019","unstructured":"Baily C, O\u2019Neill V, Dunne M, Cunningham M, Gullo G, Kennedy S, et al. Uveal melanoma in Ireland. Ocul Oncol Pathol. 2019;5:195\u2013204.","journal-title":"Ocul Oncol Pathol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0622-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0622-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0622-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:08:39Z","timestamp":1684616919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0622-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,25]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["622"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0622-9","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,25]]},"assertion":[{"value":"11 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}